NEOCHORD SECURES $20 MILLION SERIES C FINANCING

EDEN PRAIRIE, MN, June 9, 2015—NeoChord Inc. – a medical technology company, announced today it has closed an oversubscribed $20 million Series C financing round led by Deerfield Management, with participation from Baird Capital’s Venture Capital group, and existing investors Hopen Life Science Ventures, CHV Fund, TGAP Ventures, and Heron Capital. The company will use the proceeds in areas such as clinical and regulatory advancements, sales and marketing, research and development and working capital.

Read more: NEOCHORD SECURES $20 MILLION SERIES C FINANCING